Computational study of missense mutations in phenylalanine hydroxylase
Jazyk angličtina Země Německo Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- fenotyp MeSH
- fenylalaninhydroxylasa chemie genetika MeSH
- fenylketonurie genetika patologie MeSH
- genotyp MeSH
- konformace proteinů MeSH
- lidé MeSH
- missense mutace genetika MeSH
- počítačová simulace MeSH
- simulace molekulární dynamiky MeSH
- vztahy mezi strukturou a aktivitou MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- fenylalaninhydroxylasa MeSH
Hyperphenylalaninemia (HPA) is one of the most common metabolic disorders. HPA, which is transmitted by an autosomal recessive mode of inheritance, is caused by mutations of the phenylalanine hydroxylase gene. Most mutations are missense and lead to reduced protein stability and/or impaired catalytic function. The impact of such mutations varies, ranging from classical phenylketonuria (PKU), mild PKU, to non-PKU HPA phenotypes. Despite the fact that HPA is a monogenic disease, clinical data show that one PKU genotype can be associated with more in vivo phenotypes, which indicates the role of other (still unknown) factors. To better understand the phenotype-genotype relationships, we analyzed computationally the impact of missense mutations in homozygotes stored in the BIOPKU database. A total of 34 selected homozygous genotypes was divided into two main groups according to their phenotypes: (A) genotypes leading to non-PKU HPA or combined phenotype non-PKU HPA/mild PKU and (B) genotypes leading to classical PKU, mild PKU or combined phenotype mild PKU/classical PKU. Combining in silico analysis and molecular dynamics simulations (in total 3 μs) we described the structural impact of the mutations, which allowed us to separate 32 out of 34 mutations between groups A and B. Testing the simulation conditions revealed that the outcome of mutant simulations can be modulated by the ionic strength. We also employed programs SNPs3D, Polyphen-2, and SIFT but based on the predictions performed we were not able to discriminate mutations with mild and severe PKU phenotypes.
Zobrazit více v PubMed
J Invest Dermatol. 2007 Apr;127(4):829-34 PubMed
Eur J Hum Genet. 1999 Apr;7(3):386-92 PubMed
PLoS One. 2013 Nov 14;8(11):e79482 PubMed
Nature. 2012 Nov 1;491(7422):138-42 PubMed
Eur J Hum Genet. 1997 Jul-Aug;5(4):196-202 PubMed
Hum Mutat. 2009 May;30(5):703-14 PubMed
Mol Genet Metab. 2005 Dec;86 Suppl 1:S107-18 PubMed
Cell. 1996 Feb 23;84(4):575-85 PubMed
Biochim Biophys Acta. 2011 May;1812(5):602-12 PubMed
Clin Biochem. 2013 Dec;46(18):1896-8 PubMed
Biochim Biophys Acta. 2006 May;1762(5):544-50 PubMed
Clin Chim Acta. 2013 Apr 18;419:1-10 PubMed
Science. 2011 Oct 28;334(6055):517-20 PubMed
Proteins. 2006 Nov 15;65(3):712-25 PubMed
Hum Mutat. 2006 Dec;27(12):1230-43 PubMed
J Mol Biol. 2003 Oct 31;333(4):747-57 PubMed
Mol Biosyst. 2014 Oct;10(10):2567-77 PubMed
PLoS One. 2013 Dec 11;8(12):e82549 PubMed
Hum Genet. 2014 Jan;133(1):1-9 PubMed
Hum Mutat. 2003 Apr;21(4):370-8 PubMed
Biochem J. 2000 Apr 1;347 Pt 1:1-16 PubMed
Nat Struct Biol. 1997 Dec;4(12):995-1000 PubMed
Enzyme. 1987;38(1-4):286-95 PubMed
Mol Genet Metab. 2002 Nov;77(3):260-6 PubMed
Mol Genet Metab. 1999 Oct;68(2):103-25 PubMed
Nat Methods. 2010 Apr;7(4):248-9 PubMed
Nucleic Acids Res. 2013 Oct;41(18):8748-59 PubMed
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11891-4 PubMed
Am J Hum Genet. 2008 Jul;83(1):5-17 PubMed
PLoS One. 2013;8(3):e57403 PubMed
J Mol Graph. 1996 Feb;14(1):33-8, 27-8 PubMed
Gene. 2013 Oct 15;529(1):80-7 PubMed
Proteins. 1995 Dec;23(4):566-79 PubMed
Genome Res. 2001 May;11(5):863-74 PubMed
J Inherit Metab Dis. 2001 Apr;24(2):189-212 PubMed
Nat Struct Biol. 1999 May;6(5):442-8 PubMed
Hum Mutat. 2010 Jun;31(6):675-84 PubMed
Hum Mutat. 2014 Jan;35(1):27-35 PubMed
FASEB J. 2012 May;26(5):2008-18 PubMed
Arch Biochem Biophys. 2012 Mar 15;519(2):194-201 PubMed
BMC Bioinformatics. 2006 Mar 22;7:166 PubMed
Am J Hum Genet. 1998 Jun;62(6):1302-11 PubMed
Mol Genet Metab. 2010 Feb;99(2):109-15 PubMed
Am J Hum Genet. 2007 Nov;81(5):1006-24 PubMed
J Mol Biol. 1976 Jul 25;105(1):1-12 PubMed
Mol Cell Endocrinol. 2009 Dec 10;313(1-2):17-22 PubMed
Proc Natl Acad Sci U S A. 1994 Sep 27;91(20):9297-301 PubMed
Mol Genet Metab. 2001 Feb;72(2):132-43 PubMed
Hum Mutat. 2014 Mar;35(3):318-28 PubMed
Am J Hum Genet. 1998 Jul;63(1):71-9 PubMed
J Biol Chem. 1998 Jul 3;273(27):16962-7 PubMed
Science. 1974 Sep 6;185(4154):862-4 PubMed
J Mol Biol. 1993 Dec 5;234(3):779-815 PubMed